News Briefs

July 25, 2014 - 10:15am

The U.S. Food and Drug Administration has approved Targiniq ER, an extended-release/long-acting opioid analgesic with abuse-deterrent properties.

July 24, 2014 - 11:51am

Boston-area teenagers who showed heightened amygdala response when viewing negative emotional images the year before the Boston Marathon bombing were more likely to display PTSD symptoms afterwards.

July 24, 2014 - 9:34am

Programs teaching "mindfulness" and "positive psychology" both helped mothers of children with autism and other neurodevelopmental disabilities to reduce their stress, anxiety and depression.

July 23, 2014 - 9:12am

A patient’s level of C-reactive protein may predict whether he or she is likely to respond to a particular antidepressant.

Home

Blogs

Thu
24
Jul

In standard TMS, direct neuronal activation is limited to a depth of about 1.5 cm in cortical regions. With Deep TMS, the different design of the coil system allows for greater penetration and direct neuronal activation up to a depth of 6 cm, permitting direct excitation or inhibition of deeper brain structures.

Fri
18
Jul
Mike Myers, MD

How to Welcome Incoming Residents

Every year I struggle with what to tell our 300 incoming residents and fellows about physician health, impairment, and fitness for duty.

Wed
16
Jul

Clients can pose any number of challenges. And it is easy--but not productive--to label clients as "resistant," or "lazy" or "unmotivated."

Thu
10
Jul
Andrew Penn

Three Things Your Cannabis-Using Patients Know That You May Not

If your clinical practice is like mine, you’re seeing more patients who are using cannabis, or are more willing to admit to using the drug. Here are three tips to keep you up to date.

Spotlight

Congratulations to the Pop Quiz Challenge Winners!

Thank you to everyone who participated in the Psych Congress Pop Quiz challenge. We’re pleased to congratulate grand prize winner Baowu Wang, MD, as well as runners up Lydia Weisser, DO, and Meredith Mona, MD. 

Exclusives

Mixed Features in DSM-5: Explaining a Confusing Change

Q&A with Roger S. McIntyre, MD, FRCPC, Professor of Psychiatry and Pharmacology at University of Toronto based on his APA session titled, "Treating Depression With DSM-5-Defined Mixed Specifier.”

Fri
25
Jul

FDA Approves Abuse-Deterrent Opioid

The U.S. Food and Drug Administration has approved Targiniq ER, an extended-release/long-acting opioid analgesic with abuse-deterrent properties.

Thu
24
Jul

The Role of Glutamate in Schizophrenia

Leslie Citrome, MD, MPH, Clinical Professor of Psychiatry and Behavioral Sciences at New York Medical College, highlights what recent research shows regarding the role of glutamate in schizophrenia.

Thu
24
Jul

Brain Responses to Negative Images May Predict PTSD Risk

Boston-area teenagers who showed heightened amygdala response when viewing negative emotional images the year before the Boston Marathon bombing were more likely to display PTSD symptoms afterwards.

Thu
24
Jul

In standard TMS, direct neuronal activation is limited to a depth of about 1.5 cm in cortical regions. With Deep TMS, the different design of the coil system allows for greater penetration and direct neuronal activation up to a depth of 6 cm, permitting direct excitation or inhibition of deeper brain structures.